Prior studies found that psychosocial stressors are associated with hypertension, ischemic stroke, and important racial ... cerebral hemisphere), nonlobar (involving predominantly the basal ganglia, ...

Wendy Ziai started the session discussing the MISTIE technique for Anterior Basal Ganglia (ABG ... Tudor Jovin concluded the session by discussing how lessons from large core ischemic stroke trials ...

Their analysis identified magnetic resonance imaging (MRI) segmentation and enlarged perivascular spaces in the Basal ganglia as recent research ... as a mediator of poor outcomes following ischemic ...

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults. TNKase is delivered as a ...

The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according to the manufacturer. Genentech said in a press release that TNKase ...

The basal ganglia are a set of subcortical structures that interact with the cerebral cortex to regulate motor, cognitive and affective function through reinforcement learning and action selection.

The AcT (Alteplase compared to Tenecteplase) trial compared TNKase to Activase in treating patients with acute ischemic stroke that presented with a disabling neurological deficit. This ...

Mini stroke, also known as a transient ischemic attack (TIA) is a short period of symptoms that are similar to that of a stroke. It is like a temporary stroke wherein there's a temporary lack of ...

The US Food and Drug Administration has approved the thrombolytic tenecteplase for the treatment of patients with acute ischemic stroke, manufacturer Genentech announced today. The approval is based ...

In the US, the rate of ischemic stroke among adults aged 20 to 44 surged from 17 per 100,000 adults in 1993 to 28 per 100,000 in 2015. The risk of stroke death among young adults is also on the rise.